Skip to main content

Advertisement

Log in

Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington’s disease individuals

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Huntington’s disease (HD) is associated with expansion of polyglutamine tract in a protein named huntingtin (htt) that is expressed in virtually all body tissues. Thus mutated htt (HD-htt) might affect all organs, although clinical manifestations of HD are associated with selective loss of corticostriatal neurons of the brain. In this work we studied how HD-htt affects mitochondria in human peripheral blood cells. We compared various functions of mitochondria isolated from cultured lymphoblastoid cells derived from three HD patients with juvenile onset of the disease (HD-LBM) and three age-matched control (C-LBM) individuals. Respiratory parameters in different metabolic states, with succinate and glutamate plus malate were the same for all control and HD cell lines. State 4 membrane potential in HD-LBM was slightly lower than in C-LBM. The calcium retention capacity (CRC) of mitochondria was estimated using simultaneously several methods to register permeability transition (PT). We found that LBM do not undergo swelling upon Ca2+-induced PT, and do not increase CRC in the presence of ADP + oligomycin. Although each cell line had different CRC values, qualitatively PT was different in C-LBM and HD-LBM. With C-LBM cyclosporin A (CsA) increased CRC significantly, while with HD-LBM CsA was ineffective. In C-LBM depolarization of mitochondria and a large pore opening (PT) always occurred simultaneously. In HD-LBM depolarization occurred at 20–50% lower Ca2+ loads than PT. We suggest that HD-htt promotes low H+ conductance of the mitochondria by interacting with proteins at the contacts sites without directly promoting PT or hampering mitochondrial oxidative phosphorylation. (Mol Cell Biochem 269: 143–152, 2005)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Petersen A, Mani K, Brundin P: Recent advances on the pathogenesis of Huntington’s disease. Experim Neurology 157: 1–18, 1999

    Google Scholar 

  2. Rigamonti D, Nauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A, Hayden MR, Li Y, Cooper JK, Ross CA, Govoni S, Vincenz C, Cattaneo E: Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20: 3705–3713, 2000

    Google Scholar 

  3. Liu YF: Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J Biol Chem 273: 28873–28877, 1998

    Google Scholar 

  4. Lear JD: Polyglutamine toxicity: A new idea for a tough problem. Biophys J 78: 2733–2734, 2000

    Google Scholar 

  5. Saudou F, Finkbeiner S, Devys D, Greenberg ME: Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55–66, 1998

    Article  CAS  PubMed  Google Scholar 

  6. Cummings CJ, Zoghbi HY: Trinucleotide repeats: Mechanisms and pathophysiology. Ann Rev Hum Genet 1: 281–328, 2000

    Google Scholar 

  7. Schapira AH: Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia. Biochim Biophys Acta 1410:159–170, 1999

    Google Scholar 

  8. Vonsattel JP, DiFiglia M: Huntington’s disease. J Neuropathol Exp Neurol 57: 369–384, 1998

    CAS  PubMed  Google Scholar 

  9. Strong TV, Tagle DA, Valdes JM: Widespread expression of the human and rat Huntington’s disease gene in brain and non-neural tissues. Nat Genet 5: 259–265, 1993

    Google Scholar 

  10. Nicholls DG, Budd SL: Mitochondria and neuronal survival. Physiol Rev 80: 315–360, 2000

    Google Scholar 

  11. Bernardi P: Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol Rev 79: 1127–1155, 1999

    Google Scholar 

  12. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233–249, 1999

    Google Scholar 

  13. Petit PX, Susin S-A, Zamzami N, Mignotte B, Kroemer G: Mitochondria and programmed cell death: Back to the future. FEBS Letters 396: 7–13, 1996

    Google Scholar 

  14. Panov A, Obertone T, Bennett-Desmelik J, Greenamyre JT: Ca2+-dependent permeability transition and Complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington’s or Alzheimer’s disease. Ann NY Acad Sci 893: 365–368, 1999

    Google Scholar 

  15. Beutner G, Ruck A, Riede B, Brdiczka D: Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1368: 7–18, 1998

    Google Scholar 

  16. Shimizu S, Narita M, Tsujimoto Y: Bcl-2 family proteins regulate therelease of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483–487, 1999

    Article  CAS  PubMed  Google Scholar 

  17. Panov A, Andreeva L, Greenamyre JT: Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: Comparison of rat liver and brain mitochondria. Arch Biochem Biophys,in press

  18. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC: The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461–465, 2004

    Article  CAS  PubMed  Google Scholar 

  19. Kushnareva YuE, Campo ML, Kinnally KW, Sokolove PM: Signal presequences increase mitochondrial permeability and open multiple conductance channel. Arch Biochem Biophys 366: 107–115, 1999

    Google Scholar 

  20. Trounce IA, Kim YL, Jun AS, Wallace DC: Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484–509, 1996

    Google Scholar 

  21. Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF, Jr, Greenamyre JT, Snyder SH, Ross CA: Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nature Medicine 5: 1194–1198, 1999

    Google Scholar 

  22. Panov AV, Gutekunst C-A, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT: Early mitochondrial calcium defects in Huntington’s Disease area direct effect of polyglutamines. Nature Neurosci 5: 731–736, 2002

    Google Scholar 

  23. Wallace DC: Mitochondrial diseases in man and mouse. Science 283: 1482–1488, 1999

    Article  CAS  PubMed  Google Scholar 

  24. Brustovetsky N, Brustovetsky T, Jemmerson R, Dubinsky JM: Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem 80: 207–218, 2000

    Google Scholar 

  25. Shabalina IG, Panov AV: Control of energization of the liver mitochondria at the level of the adenine nucleotides carrier under condition of low tonicityof the incubation medium. Biochemistry (Moscow) 56: 282–287, 1991

    Google Scholar 

  26. Panov A, Filippova S, Lyakhovich V: Adenine nucleotide translocase as a site of regulation by ADP of the rat liver mitochondria permeability to H+ and K+ ions. Arch Biochem Biophys 199: 420–426, 1980

    Google Scholar 

  27. Panov A, Scarpa A: Mg2+ control of respiration in isolated rat liver mitochondria. Biochemistry 35: 12849–12856, 1996

    Google Scholar 

  28. LaNoue KF, Strzelecki T, Strzelecka D, Koch C: Regulation of the uncoupling protein in brown adipose tissue. J Biol Chem 261: 298–305, 1986

    Google Scholar 

  29. Halestrap AP, McGivan JD: Measurement of membrane transport phenomena. In: H.L. Kornberg, J.C. Metcalfe, D.H. Northcote, C.I. Pogson, K.F. Tipton (eds). Techniques in Meta bolic Research. Elsevier/North-Holland, Amsterdam, 1989, Vol. B206, pp 1–23

    Google Scholar 

  30. Tsien RY, Rink TJ: Neutral carrier ion-selective microelectrodes for measurement of intracellular free calcium. Biochim Biophys Acta 599: 623–638, 1980

    Google Scholar 

  31. Chalmers S, Nicholls DG: The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem 278: 19062–19070, 2003

    Google Scholar 

  32. Tabrizi SJ, Cleeter MWJ, Xuereb J, Taanman J-W, Cooper JM, Schapira AHV: Biochemical abnormalities and excitotoxicity in Huntington’s disease brain. Ann Neurol 45: 25–32, 1999

    Article  CAS  PubMed  Google Scholar 

  33. Tatton WG, Olanow CW: Apoptosis in neurodegenerative diseases: The role of mitochondria. Biochim Biophys Acta 1410: 195–213, 1999

    Google Scholar 

  34. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF: Energy metabolism defects in Huntington’s disease and effects of coenzyme Q. Ann Neurol 41: 160–165, 1997

    Google Scholar 

  35. Cortopassi GA, Wong A: Mitochondria in organismal aging and degeneration. Biochim Biophys Acta 1410: 183–193, 1999

    Google Scholar 

  36. Rego AC, Oliveira CR: Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28: 1563–1574, 2003

    Google Scholar 

  37. Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA, Borchelt DR, Tapscott SJ, Young AB, Cha JH, Olson JM: Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease. Human Mol Genet 9: 1259–1271, 2000

    Google Scholar 

  38. Krohn, AJ, Wahlbrink T, Prehn JHM: Mitochondrial depolarization is not required for neuronal apoptosis. J Neurosci 19: 7394–7404, 1999

    Google Scholar 

  39. Savage MK, Reed DJ: Release of mitochondrial glutathione and calciumby a cyclosporin A-sensitive mechanism occurs without large amplitude swelling. Arch Biochem Biophys 315: 142–152, 1994

    Google Scholar 

  40. Mannella CA, Pfeiffer DR, Bradshaw PC, Moraru II, Slepchenko B, LoewLM, Hsieh C-E, Buttle K, Marko M: Topology of the mitochondrial inner membrane: Dynamics and bioenergetic implications. IUBMB Life 52: 93–100, 2001

    Google Scholar 

  41. Panov AV, Burke JR, Strittmatter WJ, Greenamyre JT: In vitro effectsof polyglutamine tracts on Ca2+-dependent depolarization of rat liver and human lymphoblast mitochondria: Relevance to Huntington’s disease. ArchBiochem Biophys 410: 1–6, 2003

    Google Scholar 

  42. Kushnareva YE, Sokolove PM: Prooxidants open both the mitochondrial permeability transition pore and a low-conductance channel in the inner mitochondrial membrane. Arch Biochem Biophys 376: 377–388, 2000

    Google Scholar 

  43. Nicholls DG, Ferguson SJ: Bioenergetics 3. Academic Press, London 2002

    Google Scholar 

  44. Monoi H, Futaki S, Kugimiya S-C, Minakata H, Yoshihara K: Poly-l-glutamine forms cation channels: Relevance to the pathogenesis of the polyglutamine diseases. Biophys J 78: 2892–2899, 2000

    Google Scholar 

  45. Norremolle A, Grunnet M, Hasholt L, Sorensen SA: Cells exposed to a huntingtin fragment containing an expanded polyglutamine tract show no sign of ion channel formation: Results arguing against the ion channel hypothesis. J Neurosci Res 71: 132–137, 2003

    Google Scholar 

  46. Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, Cattaneo E, Hackam A, Sharp A, Thornberry N, Nicholson DW, Bredesen DE, Hayden MR: Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and non-neuronal cells. J Biol Chem 275: 19831–19838, 2000

    Google Scholar 

  47. Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, Wieloch T, Elmer E: Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 960: 99–11, 2002

    Google Scholar 

  48. Schapira AHV: Mitochondrial function in Huntington’s disease: Clues for pathogenesis and prospects for treatment. Ann Neurol 41: 141–142, 1997

    Google Scholar 

  49. Nishino H, Hida H, Kumazaki M, Shimano Y, Nakajima K, Shimizu H, Ooiwa T, Baba H: The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: A hypothesis to explain its specific vulnerability. J Neurotrauma 17(3): 251–260, 2000

    Google Scholar 

  50. Greene JG, Greenamyre JT: Bioenergetics and glutamate excitotoxicity. Progr Neurobiol 48: 613–634, 1996

    Google Scholar 

  51. Alexia T, Borlongand CV, Faullb RLM, Williamsa CE, Clarka RG, Gluckmana PD, Hughesc PE: Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases. Progr Neurobiol 60: 409–470, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander V. Panov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panov, A.V., Lund, S. & Greenamyre, J.T. Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington’s disease individuals. Mol Cell Biochem 269, 143–152 (2005). https://doi.org/10.1007/s11010-005-3454-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-3454-9

Keywords

Navigation